Gene · 1441
Papers3,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects. | PLoS One | 2024 | 38306344 | PubTator, text mining | PubMed |
| Prognostic and immune roles of UROC1 in human cancers: from mechanism exploration of NAFLD and HCC to pan-cancer analysis. | Eur Rev Med Pharmacol Sci | 2024 | 38305606 | PubTator, text mining | PubMed |
| Endogenus chondrocytes immobilized by G-CSF in nanoporous gels enable repair of critical-size osteochondral defects. | Mater Today Bio | 2024 | 38283982 | PubTator, text mining | PubMed |
| CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I mutation. | Br J Haematol | 2024 | 38262633 | PubTator, text mining | PubMed |
| Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins. | Cancers (Basel) | 2024 | 38254802 | PubTator, text mining | PubMed |
| Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. | Blood Cancer J | 2024 | 38253683 | PubTator, text mining | PubMed |
| Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia. | Cell Rep Med | 2024 | 38232702 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Sequencing Reveals Tissue Architecture and Deciphers Pathological Reprogramming During Retinal Ischemia in Macaca fascicularis. | Invest Ophthalmol Vis Sci | 2024 | 38214685 | PubTator, text mining | PubMed |
| Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis. | Case Rep Hematol | 2024 | 38213502 | PubTator, text mining | PubMed |
| The intricate cellular ecosystem of human peripheral veins as revealed by single-cell transcriptomic analysis. | PLoS One | 2024 | 38206912 | PubTator, text mining | PubMed |
| Machine Learning Made Easy (MLme): a comprehensive toolkit for machine learning-driven data analysis. | Gigascience | 2024 | 38206587 | PubTator, text mining | PubMed |
Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial. | Support Care Cancer | 2024 | 38194162 | PubTator, text mining | PubMed |
| Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. | Ther Adv Hematol | 2024 | 38186638 | PubTator, text mining | PubMed |
| Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning. | Commun Biol | 2024 | 38182876 | PubTator, text mining | PubMed |
| Transcriptomic analysis identifies diagnostic genes in polycystic ovary syndrome and periodontitis. | Eur J Med Res | 2024 | 38167332 | PubTator, text mining | PubMed |
| The RNA m6A demethylase ALKBH5 drives emergency granulopoiesis and neutrophil mobilization by upregulating G-CSFR expression. | Cell Mol Immunol | 2024 | 38114747 | PubTator, text mining | PubMed |
| Sequential tumor molecular profiling identifies likely germline variants. | Genet Med | 2024 | 38054407 | PubTator, text mining | PubMed |
CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration. | Pathol Int | 2024 | 38050833 | PubTator, text mining | PubMed |
| Single-Cell Atlas of Human Ovaries Reveals The Role Of The Pyroptotic Macrophage in Ovarian Aging. | Adv Sci (Weinh) | 2024 | 38036420 | PubTator, text mining | PubMed |
| Research progress of additional pathogenic mutations in chronic neutrophilic leukemia. | Ann Hematol | 2024 | 37993585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1441/papers?page=10